Drug profile · INN
epoprostenol sodium
EPOPROSTENOL ACT PARTIAL CHANGE APPROVAL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
epoprostenol sodium (EPOPROSTENOL ACT PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is epoprostenol sodium?
epoprostenol sodium (EPOPROSTENOL ACT PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for epoprostenol sodium?
EPOPROSTENOL ACT PARTIAL CHANGE APPROVAL is a marketed brand name for epoprostenol sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of epoprostenol sodium?
epoprostenol sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.